Dimitris Fagkrezos, Marina Kakavelou, Evgenia Charitaki, Spiros Delis, Kleo Papaparaskeva, Charikleia Triantopoulou, Petros Maniatis, Dimosthenis Chrysikos, Theodore Troupis
BACKGROUND/AIM: Inflammatory myofibroblastic tumors (IMTs) are rare, solid, potentially malignant lesions of uncertain etiology. Histologically, IMTs exhibit a combination of lymphocytes and inflammatory cells within a fibroblastic myxoid layer. The diagnosis of IMTs poses a challenge for various medical specialties, including surgeons, pathologists, and oncologists, due to their non-specific clinical presentation. Furthermore, radiologists face difficulties in interpreting computed tomography (CT) or magnetic resonance imaging (MRI) results, which often yield polymorphic and inconclusive findings...
2024: Cancer Diagn Progn